ArticleFrontiers in oncology2026

Tislelizumab-induced hyperosmolar diabetic ketoacidosis complicated with rhabdomyolysis in hepatocellular carcinoma patients: case report.

Longjun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.